Saudi Arabia Cell And Gene Therapy Manufacturing Market Size & Outlook

The cell and gene therapy manufacturing market in Saudi Arabia is expected to reach a projected revenue of US$ 120.0 million by 2030. A compound annual growth rate of 16.8% is expected of Saudi Arabia cell and gene therapy manufacturing market from 2023 to 2030.
Revenue, 2022 (US$M)
$34.7
Forecast, 2030 (US$M)
$120.0
CAGR, 2023 - 2030
16.8%
Report Coverage
Saudi Arabia

Saudi Arabia cell and gene therapy manufacturing market, 2018-2030 (US$M)

Saudi

Saudi Arabia cell and gene therapy manufacturing market highlights

  • The Saudi Arabia cell and gene therapy manufacturing market generated a revenue of USD 34.7 million in 2022 and is expected to reach USD 120.0 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 16.8% from 2023 to 2030.
  • In terms of segment, cell therapy was the largest revenue generating therapy type in 2022.
  • Gene Therapy is the most lucrative therapy type segment registering the fastest growth during the forecast period.


Cell and gene therapy manufacturing market data book summary

Market revenue in 2022USD 34.7 million
Market revenue in 2030USD 120.0 million
Growth rate16.8% (CAGR from 2022 to 2030)
Largest segmentCell therapy
Fastest growing segmentGene Therapy
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGene Therapy, Cell Therapy
Key market players worldwideLonza Group Ltd, Bluebird bio Inc, Catalent Inc, Roche, Samsung BioLogics, Boehringer Ingelheim, Hitachi Ltd, Takara Bio Inc, Miltenyi Biotec, Thermo Fisher Scientific Inc, Novartis AG ADR, Merck KGaA, Wuxi AppTec Co Ltd


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.5% of the global cell and gene therapy manufacturing market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa cell and gene therapy manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 180.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell And Gene Therapy Manufacturing Market Companies

Name Profile # Employees HQ Website

Saudi Arabia cell and gene therapy manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy manufacturing market will help companies and investors design strategic landscapes.


Cell therapy was the largest segment with a revenue share of 67.15% in 2022. Horizon Databook has segmented the Saudi Arabia cell and gene therapy manufacturing market based on gene therapy, cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.


Saudi Arabia has become the first Arabian country with more than 10,000 stem cell donors. This indicates the increasing adoption of stem cell therapies in the country. In the gene therapy space, researchers from KAUST, Saudi Arabia, have developed a new delivery system for introduction of gene editing technology into cells.

Such active engagement in this field is expected to increase the demand for cell and gene therapy manufacturing services for precommercial applications in the country. In addition, major companies such as Celltex Therapeutics Corporation are expanding their business in Saudi Arabia.

In March 2019, Celltex Therapeutics Corporation signed a Memorandum of Understanding with Research Products Development Company (RPDC), Saudi Arabia, for commercialization of the company's stem cell technology. Such initiatives are anticipated to propel market growth in the country.

Reasons to subscribe to Saudi Arabia cell and gene therapy manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia cell and gene therapy manufacturing market databook

  • Our clientele includes a mix of cell and gene therapy manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia cell and gene therapy manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia cell and gene therapy manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia cell and gene therapy manufacturing market size, by therapy type, 2018-2030 (US$M)

Saudi Arabia Cell And Gene Therapy Manufacturing Market Outlook Share, 2022 & 2030 (US$M)

Saudi Arabia cell and gene therapy manufacturing market size, by therapy type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more